Varicella Zoster Vaccines
- Name
- Varicella Zoster Vaccines
- Accession Number
- DBCAT003222 (DBCAT003202)
- Description
A live, attenuated varicella virus vaccine used for immunization against chickenpox. It is recommended for children between the ages of 12 months and 13 years.
- ATC Classification
- Drugs
Drug Drug Description Varicella zoster vaccine (live/attenuated) Zostavax vaccine is indicated for the prevention of herpes zoster (shingles) in immunocompetent adults aged 50 years and older. Varivax vaccine is indicated for active immunization for the prevention of... Varicella zoster vaccine (recombinant) Varicella zoster vaccine is indicated for the prevention of herpes zoster (HZ) (shingles) in adults aged 50 years and older and in adults aged 18 years and older who are... - Drugs & Drug Targets
Drug Target Type